Task: Answer the multiple-choice question.
Question: Which drug exhibits a -24.865% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: COc1ccc(N2CCN(CCCNC(=O)C3CCCN(S(=O)(=O)c4c(C)n[nH]c4C)C3)CC2)cc1
b: Cc1cccc(NC(=O)c2cc(Cl)ccc2[N+](=O)[O-])c1
Answer: b. Cc1cccc(NC(=O)c2cc(Cl)ccc2[N+](=O)[O-])c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(NC(=O)c2cc(Cl)ccc2[N+](=O)[O-])c1
Cc1cccc(NC(=O)c2cc(Cl)ccc2[N+](=O)[O-])c1
5-chloro-N-(3-methylphenyl)-2-nitrobenzamide